GlassScriptPhysician profile
Brandy L Arrol
NPI 1073804472
$1,489.68
in general payments reported to CMS, 2019-2025
13 companies · $844 in 2025
The $844 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.54 · 2023: $56.69 · 2024: $572 · 2025: $844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.14 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $786.88 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $245.30 | 2025 | Erleada |
| Antares Pharma, INC. | $156.82 | 2024-2025 | Xyosted, Tlando |
| Progenics Pharmaceuticals, INC. | $66.00 | 2024-2025 | |
| 180 Medical, INC. | $39.50 | 2024-2025 | Gentlecath Glide, Gentlecath |
| Immunitybio, INC. | $34.42 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $32.12 | 2021-2024 | Fasenra |
| Axonics, INC. | $25.39 | 2024 | Axonics |
| Endo USA, INC. | $21.40 | 2025 | Xiaflex |
| Laborie Medical Technologies Corp. | $21.17 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Abbvie INC. | $20.73 | 2024 | |
| Myriad Genetic Laboratories, INC. | $20.12 | 2024 | Prolaris |
| Astellas Pharma US INC | $19.83 | 2024 | Myrbetriq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Arrol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.